Company Filing History:
Years Active: 1997-1999
Title: Innovations and Contributions of Kathleen Ann Becherer
Introduction
Kathleen Ann Becherer is a notable inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of methods and compositions for drug screening and disease treatment. With a total of 4 patents to her name, her work has had a meaningful impact on medical research and therapeutic applications.
Latest Patents
One of her latest patents is titled "Compositions and methods for screening drug libraries." This invention describes a method for screening binding partners of a specific molecule using a chimeric protein with multiple binding regions. This innovative approach allows for the rapid screening of compounds in combinatorial libraries to identify potential biological activity. Another significant patent is for "Oligonucleotides specific for cytokine signal transducer gp130 mRNA." This invention focuses on oligonucleotides that inhibit disease-associated cellular proliferation, particularly in the context of cancer, autoimmune disorders, and viral infections. These oligonucleotides are designed to be complementary to gp130 mRNA sequences and can be formulated into pharmaceutical compositions for human treatment.
Career Highlights
Throughout her career, Kathleen has worked with prominent companies such as Gen-Probe, Inc. and Chugai Pharmaceutical Co. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical technology and therapeutic solutions.
Collaborations
Kathleen has collaborated with esteemed colleagues, including Nanibhushan Dattagupta and Yathi M Naidu. These partnerships have fostered a collaborative environment that enhances the development of her inventions and research initiatives.
Conclusion
Kathleen Ann Becherer is a distinguished inventor whose work in biotechnology has led to significant advancements in drug screening and disease treatment. Her innovative patents and collaborations reflect her commitment to improving healthcare through scientific research and development.